These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 240938)

  • 61. Isolation and structure of T-kinin.
    Okamoto H; Greenbaum LM
    Biochem Biophys Res Commun; 1983 Apr; 112(2):701-8. PubMed ID: 6847671
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis of bradykinyl-Val-Ala-Pro-Ala-Ser-OH and its biological propertieS.
    Yanaihara N; Yanaihara C; Sakagami M; Nakajima T; Nakayama T
    Chem Pharm Bull (Tokyo); 1973 Mar; 21(3):616-21. PubMed ID: 4727348
    [No Abstract]   [Full Text] [Related]  

  • 63. Are prostaglandins involved in the action of bradykinin and oxytocin on the rat uterus in vitro and in vivo? [proceedings].
    Whalley ET; Raynes G
    J Endocrinol; 1979 May; 81(2):134P-135P. PubMed ID: 458315
    [No Abstract]   [Full Text] [Related]  

  • 64. Amplification of the bradykinin response in rat uterus by pCMB-Dextran T 10.
    Mann K; Bachhuber F; Kather H; Simon B
    Agents Actions; 1975 Aug; 5(3):236-8. PubMed ID: 1236639
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacological effects and metabolism of neurotensin and bradykinin in the isolated rat uterus.
    Lebrun I; Camargo AC; Correa FM
    Eur J Pharmacol; 1988 Mar; 148(2):231-7. PubMed ID: 3378572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bradykinin antagonists with dehydrophenylalanine analogues at position 5.
    Greiner G; Dornberger U; Paegelow I; Schölkens BA; Liebmann C; Reissmann S
    J Pept Sci; 1998 Apr; 4(2):92-100. PubMed ID: 9620613
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of oxytocic and hypotensive activities of bradykinin by bradykinin-binding antibodies.
    Marin Grez M; Marin Grez MS; Peters G
    Eur J Pharmacol; 1974 Nov; 29(1):35-42. PubMed ID: 4373254
    [No Abstract]   [Full Text] [Related]  

  • 68. Synthesis of bradykinin via oximinopyrazoline active esters (OPmp).
    Tomatis R; Ferroni R; Guarneri M; Benassi CA
    J Med Chem; 1973 Sep; 16(9):1053-4. PubMed ID: 4745509
    [No Abstract]   [Full Text] [Related]  

  • 69. Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
    Amblard M; Bedos P; Olivier C; Daffix I; Luccarini JM; Dodey P; Pruneau D; Paquet JL; Martinez J
    J Med Chem; 2000 Jun; 43(12):2382-6. PubMed ID: 10882364
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis of bradykinin fragments and their analogs modified at a phenylalanine residue.
    Okada Y; Tsuda Y; Yagyu M
    Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):310-3. PubMed ID: 7363374
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of endothelins, Bay K 8644 and other oxytocics in non-pregnant and late pregnant rat isolated uterus.
    Calixto JB; Rae GA
    Eur J Pharmacol; 1991 Jan; 192(1):109-16. PubMed ID: 1710186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chimeric strategies for the rational design of bioactive analogs of small peptide hormones.
    Howl J; Langel U; Hawtin SR; Valkna A; Yarwood NJ; Saar K; Wheatley M
    FASEB J; 1997 Jun; 11(7):582-90. PubMed ID: 9212082
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bradykinin agonist activity of a novel, potent oxytocin antagonist.
    Pettibone DJ; Clineschmidt BV; Lis EV; Ransom RW; Totaro JA; Young GS; Bock MG; Freidinger RM; Veber DF; Williams PD
    Eur J Pharmacol; 1991 Apr; 196(3):233-7. PubMed ID: 1893911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Potentiating effects of bradykinin-related substances on bradykinin-induced contraction of guinea pig ileum and hypotension in rats.
    Naruse M; Yamanami S; Shuto K; Sakakibara S; Kimura T
    Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3369-74. PubMed ID: 7337937
    [No Abstract]   [Full Text] [Related]  

  • 76. Synthesis, characterization, and conformational analysis of the D/L-Tic7 stereoisomers of the bradykinin receptor antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin.
    Sawutz DG; Salvino JM; Seoane PR; Douty BD; Houck WT; Bobko MA; Doleman MS; Dolle RE; Wolfe HR
    Biochemistry; 1994 Mar; 33(9):2373-9. PubMed ID: 8117696
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Synthesis of a nonapeptide with oxytocin activity].
    Rimpler M; Schöberl A
    Naturwissenschaften; 1969 Dec; 56(12):638-9. PubMed ID: 5375109
    [No Abstract]   [Full Text] [Related]  

  • 78. [Cyclic analogs of bradykinin, containing a carboxyl group].
    Mutule IE; Mutulis FK; Myshliakova NV; Veveris MM; Golubeva VV; Porunkevich EA; Ratkevich MP; Strazda GM; Klusha VE; Bergmann Iu
    Bioorg Khim; 1990 Nov; 16(11):1465-76. PubMed ID: 1710895
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro contractile response of human myometrium to oxytocin, PGF2alpha, bradykinin and ET-1.
    Janicek F; Franova S; Nosalova G; Visnovsky J
    Bratisl Lek Listy; 2007; 108(4-5):174-8. PubMed ID: 17694800
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.